StockGuru News: EntreMetrix Launches Pharmaceutical Portfolio Investment With PreVantix
EntreMetrix Launches Pharmaceutical Portfolio Investment With PreVantix EntreMetrix Corporation (OTCBB: ERMX) IRVINE, CA–(MARKET WIRE)–Jul 5, 2006 — EntreMetrix, Inc. (OTC BB:ERMX.OB - News) today announced the launch of a new portfolio investment within the pharmaceutical industry. The new portfolio company, PreVantix, will focus on the commercialization of patented pharmaceutical science and technologies which address disease management and preventive medicine applications. In an expanded introduction of PreVantix, Scott W. Absher, the Company’s CEO, stated, “To participate with PreVantix in the launch of their initial products and market entry into the fastest growing segment of medical care in America is a very…